RNS: AMP sale of MTFB shares21 Aug 2018 08:18
"London and New York: Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that 3,000,000 shares in Partner Company, Motif Bio plc ("Motif"), have been sold directly to an institutional investor at 33.5 pence per share (the "Motif Shares"). Net proceeds of approximately US $1,273,000 from the sale of the Motif Shares will be used as partial repayment of the loan facility (the "Facility") originally announced on 5 June 2014 with the most recent terms announced on 22 December 2017, as well as ongoing business operations and development of Amphion's other Partner Companies. Following this sale, Amphion's holding will represent 8.51% of the issued share capital of Motif. The Motif Shares had a book value of US $1,339,166 as at 30 June 2018."